Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Stations X's GenePool; DNAnexus' PaaS; DNAStar's Lasergene 11.2

Premium

Station X has launched GenePool, a cloud-based software application to manage, analyze, and communicate genomic and clinical information. Users can analyze sequence information from both DNA and RNA to identify biomarkers. The software has a web browser interface. Users can do analysis comparisons between tumor and normal genomes, analyses comparing responders and non-responders, and trio-based analyses for genetic diseases, among other applications.


DNAnexus has launched PaaS, or platform-as-a-service to enable clinical testing laboratories to move their analysis pipelines into the cloud using their own algorithms as well as industry tools and resources to create customized workflows. According to the company, the platform enables genomic research enterprises to expand their data analysis and storage infrastructure needs into the cloud and transform large capital expenditures into transparent operating expenses.


DNAStar has launched Lasergene 11.2, a software upgrade that incorporates new sequence alignment methods and tools in the MegAlign Pro application. The new release now supports Clustal Omega, Mauve, a fully integrated Muscle alignment algorithm, and enhanced phylogenetic trees, according to the company.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.